April 30 (Reuters) - InMed Pharmaceuticals Inc IN.TO :
* INMED RECEIVES CTA APPROVAL FOR SECOND PHASE 1 CLINICAL TRIAL WITH INM-755
* INMED PHARMACEUTICALS INC - TWO STRENGTHS OF INM-755 CREAM WILL BE EVALUATED IN 8 ADULT SUBJECTS OVER A 14-DAY TREATMENT PERIOD